The Zacks analyst blog highlights applied materials, GE, AstraZeneca, team and applied energetics Zacks 3d
Truqap® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer Business Wire (Press Release) 7d